pharma · Mantle Cell Lymphoma · Colon cancer
Telethon Foundation
Fondazione Telethon ETS
Telethon Foundation clinical programs — 119 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- roma, IT
- Founded
- 1990
- Employees
- 343
- Programs
- 162
- Drugs
- 285
- Patents
- 0
Telethon Foundation projects
119 ClinicalTrials.gov programs sponsored by Telethon Foundation.
Telethon Foundation has 119 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
REVERSE
Fondazione Telethon ETS
Pseudomyxoma peritonei patients with high tumor burden.
1 trial -
RF-2021-12375251
Fondazione Telethon ETS
Refractory Systemic Autoimmune Diseases
1 trial -
RITUXIMAB, Golcadomide
Fondazione Telethon ETS
Diffuse Large B-cells non-Hodgkin Lymphoma
1 trial -
Rabipur Polvere e solvente per soluzione inie...
Fondazione Telethon ETS
X-linked immunodeficiency with hyper-IgM type 1 (HIGM1)
1 trial -
Romidepsin
Fondazione Telethon ETS
Anaplastic Large T-cell Lymphoma ALK negative, Angioimmunoblastic T-cell Lymphoma, Peripheral T-cell lymphoma, NOS
1 trial -
SMILE
Fondazione Telethon ETS
Subjects at high risk of inflammatory state and mortality from lung cancer, other cancers and all causes
1 trial -
TEBENTAFUSP
Fondazione Telethon ETS
metastatic uveal melanoma HLA A*02:01 positive
1 trial -
TECLISTAMAB, TECLISTAMAB
Fondazione Telethon ETS
refractory/relapsed multiple myeloma
1 trial -
TEDOPI for NSCLC non-small cell lung cancer
Fondazione Telethon ETS
NSCLC non-small cell lung cancer
1 trial -
TEMOZOLOMIDE , IRINOTECAN
Fondazione Telethon ETS
Stage II (pT4)/III colorectal cancer with positive circulating tumor DNA (ctDNA) after oxaliplatin-based adjuvant chemotherapy
1 trial -
TEMOZOLOMIDE for locally advanced rectal cancer (LARC)
Fondazione Telethon ETS
locally advanced rectal cancer (LARC)
1 trial -
TEPADINA for Autosomal recessive osteopetros…
Fondazione Telethon ETS
Autosomal recessive osteopetrosis caused by mutations in the TCIRG1 gene
1 trial -
TISLELIZUMAB
Fondazione Telethon ETS
Hodgkin lymphoma
1 trial -
TOCILIZUMAB for Mantle Cell Lymphoma
Fondazione Telethon ETS
Mantle Cell Lymphoma
1 trial -
TRASTUZUMAB DERUXTECAN
Fondazione Telethon ETS
metastatic HER2-positive breast cancer patients
1 trial -
TREMELIMUMAB for locally advanced cholangiocarcinoma
Fondazione Telethon ETS
locally advanced cholangiocarcinoma
1 trial -
The Placebo composition is the same of the IMP except the active ingredient
Fondazione Telethon ETS
Optic Pathway Glioma (OPG)
1 trial -
Ultravist /ml soluzione iniettabile for breast pathology
Fondazione Telethon ETS
breast pathology
1 trial -
VESPA
Fondazione Telethon ETS
Metastatic pancreatic ductal adenocarcinoma (mPDAC)
1 trial -
VINORELBINE for Hodgkin’s lymphoma
Fondazione Telethon ETS
Hodgkin’s lymphoma
1 trial -
VIZAMYL 400 MBq/mL solution for injection
Fondazione Telethon ETS
cardiac amyloidosis
1 trial -
Vectibix /ml concentrate for RAS/BRAF wild-type metastatic c…
Fondazione Telethon ETS
RAS/BRAF wild-type metastatic colorectal cancer
1 trial -
Xospata 40 mg film-coated tablets
Fondazione Telethon ETS
newly diagnosed non-M3 FLT3-positive acute myeloid leukemia
1 trial
Frequently asked questions
How many clinical projects does Telethon Foundation have?
119 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.